Home Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs
 

Keywords :   


Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs

2014-09-01 09:56:36| Biotech - Topix.net

Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product status from U.S. Food & Drug Administration .

Tags: status drugs receives fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Hurricane Beryl Update Statement
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07BASFs TECH Academy Introduces Louisiana High School Students to Technical Careers
01.07Comericas Patterson Helps Entrepreneurs Grow Their Waste and Recycling Businesses
01.07Hitachi Zosen Inova Acquires Babcock & Wilcox's Denmark-Based Renewable Parts and Services Subsidiary
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 11A
01.07Summary for Hurricane Beryl (AT2/AL022024)
More »